Investor Relations
Welcome
You have expressed an interest in investing in REVVY HEALTH LTD. Behind this page sits our investor area, containing the full document set for the current financing round.
Access is deliberately restricted. The documents contain formulations, supplier relationships, margins, cash position and shareholding details that are not intended for competitors or for the public. In addition, for legal reasons this financing round may only be directed at a narrowly defined circle of investors.
Please read the following three sections and confirm them at the foot of this page. You will then receive a personal access code by email automatically.
1. Legal notice
REVVY HEALTH LTD is a private company limited by shares incorporated in England and Wales (Companies House no. 15947074, 20 Wenlock Road, London N1 7GU, United Kingdom).
This page and the documents behind it do not constitute a public offer of securities. They are neither a prospectus within the meaning of the Swiss Financial Services Act (FinSA) nor a key information document, and they are not a prospectus for the purposes of the UK prospectus regime. No prospectus has been drawn up, reviewed or approved by any reviewing body. The documents are addressed solely to individually contacted persons who qualify as professional clients or qualified investors.
The documents constitute neither investment advice, nor tax advice, nor a recommendation to acquire an interest. They are no substitute for your own assessment. Consult your own legal, tax and financial advisers before subscribing.
Excluded are: persons resident or established in the United States of America, and "U.S. Persons" within the meaning of Regulation S under the U.S. Securities Act of 1933; persons resident or established in the United Kingdom; as well as persons in any other jurisdiction in which access to these documents or the acquisition of an interest would be unlawful. Please satisfy yourself that you are permitted to subscribe under the law of your country of residence.
Note for persons in the United Kingdom. This communication is not directed at, and must not be acted upon by, any person resident or established in the United Kingdom. No invitation or inducement to engage in investment activity is being made to any such person, and REVVY HEALTH LTD does not accept subscriptions from persons in the United Kingdom in this financing round.
All information in the documents is stated as at the date of its preparation. Projections, market estimates and forecasts are forward-looking statements resting on assumptions that may prove incorrect. No assurance is given that they will be realised.
2. Risk warning
An investment in REVVY HEALTH LTD is high risk. You should be prepared to lose the entire amount you invest.
The risks include, as a minimum:
- Total loss. REVVY is an early-stage company. If the business model fails, the shares become worthless. As a shareholder you rank behind all creditors in an insolvency.
- No liquidity. The shares are not listed on any exchange. There is no market on which you could sell them. You should assume your capital will be locked up for years, possibly permanently. The articles of association may impose further transfer restrictions.
- Dilution. Further financing rounds, an employee or ambassador equity plan, or the issue of new share classes will reduce your percentage holding and may occur on terms less favourable than your own.
- No distributions. No dividends are planned for the foreseeable future. A return can arise only from a sale of the company, which may never happen.
- Early-stage risk. The company does not yet generate material revenue and is not profitable. It depends on raising further capital. If that capital is not raised, the business cannot continue.
- Concentration. The company depends on a small number of individuals, on individual suppliers and contract manufacturers, and on a small number of sales channels. The loss of any one of these would affect trading directly.
- Regulatory risk. Food supplements are subject to market-specific rules on formulation, maximum levels, labelling and permitted health claims. Changes or regulatory challenges may affect products, copy or entire markets.
- Currency risk. Share capital and round terms are denominated in pounds sterling, while costs and revenues arise mainly in euro and Swiss francs. Exchange rates may change your outcome independently of how the business performs.
- Tax. The tax treatment of an interest in a UK company depends on your personal circumstances and may change. That risk is yours.
Invest only an amount whose complete loss would not materially affect your financial position.
3. Confidentiality undertaking
By submitting this form, the following applies between you (the "Recipient") and REVVY HEALTH LTD, Companies House no. 15947074 (the "Company"):
3.1 Confidential information. Confidential information means all information made available by the Company to the Recipient in the investor area or in connection with the financing round, in written, oral, electronic or any other form. It includes in particular business plans, financial models, figures on revenue, cost, margin and cash, shareholdings and capitalisation tables, formulations and specifications, supplier and customer relationships, pricing, legal assessments, and the fact that discussions about an investment are taking place.
3.2 Obligations. The Recipient undertakes to keep confidential information strictly confidential, to use it solely to evaluate a possible investment of its own, and not to disclose it to third parties in whole or in part. Access codes, links and files may not be passed on.
3.3 Permitted disclosure. Disclosure to the Recipient's own advisers (lawyers, tax advisers, trustees, banks) is permitted to the extent they need the information to advise the Recipient and are themselves bound to confidentiality professionally or by contract. The Recipient is liable for their conduct as for its own.
3.4 Exceptions. This does not cover information that was demonstrably already public or becomes public without the Recipient's doing, that was demonstrably already lawfully known to the Recipient, or that the Recipient received from a third party under no duty of confidence. Mandatory disclosure required by law or by an authority is reserved; the Recipient will notify the Company in advance where permitted.
3.5 Duration. These obligations take effect on submission of this form and continue for three years thereafter, whether or not an investment results. Trade secrets remain protected beyond that for as long as they remain secret.
3.6 Return and deletion. On the Company's request the Recipient will delete or destroy all documents and copies received and confirm this in writing, save for copies it must retain under statutory retention duties.
3.7 No rights, no obligation. This undertaking grants no rights in the Company's intellectual property. Neither party is obliged to enter into a transaction. The Company gives no warranty as to the completeness or accuracy of the information provided; liability arises only in cases of intent or gross negligence.
3.8 Governing law. This undertaking is governed by English law. The courts of England and Wales have exclusive jurisdiction.
By submitting the form you give this undertaking in electronic form. The date, time, IP address and the wording in force at the time of submission are recorded, and you will receive a copy by email.
4. Data protection
Your details are used solely to assess and administer your access to the investor area and to process any subscription. The legal basis is the taking of steps at your request prior to entering into a contract, together with our legitimate interest in auditable access control. The data is not used for marketing and is not sold to third parties.
Any identity check (copy of identity document, Form A) serves solely to establish the identity of the subscriber and of the beneficial owner. Those documents are held separately and with restricted access, and are deleted once the statutory retention period expires. If no subscription results, they are deleted within 90 days.
You have the right to access, rectification, erasure and objection. Please direct requests to vip@revvy.ch. Details in our privacy policy.
Confirmation and access
All fields are required. After submitting you will receive your personal access code by email at the address given, within a few minutes.
Already have an access code? Go straight to the investor area
